Correlation Between Petros Pharmaceuticals and ANI Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Petros Pharmaceuticals and ANI Pharmaceuticals, you can compare the effects of market volatilities on Petros Pharmaceuticals and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and ANI Pharmaceuticals.

Diversification Opportunities for Petros Pharmaceuticals and ANI Pharmaceuticals

-0.03

Correlation Coefficient

Petros Pharmaceuticals  ANI Pharmaceuticals

Good diversification

The 3 months correlation between Petros and ANI is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and ANI Pharmaceuticals go up and down completely randomly.

Pair Corralation between Petros Pharmaceuticals and ANI Pharmaceuticals

Given the investment horizon of 90 days Petros Pharmaceuticals is expected to generate 3.96 times more return on investment than ANI Pharmaceuticals. However, Petros Pharmaceuticals is 3.96 times more volatile than ANI Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  62.00  in Petros Pharmaceuticals on October 9, 2024 and sell it today you would lose (21.00) from holding Petros Pharmaceuticals or give up 33.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Petros Pharmaceuticals  vs.  ANI Pharmaceuticals

Petros Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Petros Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Petros Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

ANI Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, ANI Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Petros Pharmaceuticals and ANI Pharmaceuticals

The main advantage of trading using opposite Petros Pharmaceuticals and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.

The idea behind Petros Pharmaceuticals and ANI Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.